NFKK 2014

Posters

Biomarkers in heart disease

P01 Lipoprotein(a), total/HDL-cholesterol ratio, ApoB/ApoA ratio as risk factors for atherogenesis in patients with coronary artery disease

Danica Labudovic, Sonja Alabakovska, Katerina Tosheska Trajkovska, Jasna Bogdanska, Silvana Jovanova

 

P02 High Sensitive Troponin in patients with Erectile Dysfunction

Gianvico Melzi D´eril, Raffaele Pezzilli, Clara A. L. Damele, Rossana Stefanelli, Giovanni M. Colpi, Massimiliano M. Corsi Romanelli, Alessandra Barassi

 

P03 Acute pancreatitis and myocardial damage

GianVico Melzi d´Eril, Raffaele Pezzilli, Giovanni M. Colpi, Massimiliano M. Corsi Romanelli, Alessandra Barassi

 

P04 Quality assurance measurement of the cholesterol markers apolipoproteins A1 and B; Going against the grain

Joannis Kinalis, Eva Fahlen, Erika Langenstam, Erika Karabasic

 

P05 Evaluation of the Alere NT-proBNP test for point of care testing

Banafsheh Seyyed Khezri, Lena Carlsson, Anders Larsson

 

P06 Serial Troponin T testing based on stored samples on the clinical laboratory

Oscar  Oliva Torstensson, Carina Gustafsson, Birgitta Gren, Jan Friden, Ola Hammarsten

 

P07 Implementation of cardiac biomarkers in ambulatory emergency medicine department

Vaike Viia

 

P07:2 Estimation of the possible economic effects of a sequential testing strategy with NT-proBNP before echocardiography in primary care

Banafsheh  Seyyed Khezri, Johanna Helmersson-Karlqvist, Anders Larsson

 

Novel techniques

P08 An invitro assay to measure cell sensitivity to ionizing radiation

Sherin Mathew, Pegah Johansson, Ola Hammarsten

 

P09 An improved high performance liquid chromatography-fluorescence detection method for the analysis of Pimozide in human plasma samples

Alessandra Barassi, Francesca Ghilardi, Alessandra Flaminio, Roberta Marotta, GianVico Melzi d´Eril

 

P10 Validation of a new OptiScanner™ 5000 system for an intermittent glucose monitoring

Alessandra Barassi, Michele Umbrello, Clara A. L. Damele, Francesca Ghilardi, Rossana Stefanelli, Gaetano Iapichino, GianVico Melzi d´Eril

 

P11 Preparation and in vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers

Abolfazl Akbarzadeh

 

P12 Amyloidosis diagnosis by mass spectrometry

Jakob C. Albrethsen, Morten Salomo, Anders H. Johnsen

 

Biomarkers in neurodegenerative disease

P13 Plasma levels of apolipoprotein E and risk of dementia in the general population

Katrine Laura Rasmussen, Anne Tybjærg-Hansen, Børge G. Nordestgaard, Ruth Frikke-Schmidt

 

P14 Blood biomarkers for brain injury in concussed professional ice hockey players

Pashtun Shahim, Gisela Malmgård, David H. Wilson, Jeffrey Randall, Birgitta Kallberg, Yelverton Tegner, Kaj Blennow, Henrik Zetterberg

 

P15 Biomarker-determined Alzheimer prevalence in patients undergoing surgery due to hip fracture

Maria Lönnquist, Birgitta Kallberg, Kaj  Blennow, Henrik Zetterberg, Bengt Nellgård

 

Laboratory as a diagnostic partner

P16 Critical results for community based patients and audit of a two tier biochemical phone list

Jeffrey Barron, Geoff Smith

 

P17 HbA1c as the diagnostic criterion for diabetes reduces incidence and prevalence of DM2 by 25% but strongly depending on analytical quality

Ivan Brandslund, Aneta A. Nielsen, Per H. Petersen, Anders Green, Cramer K. Christensen, Henry Christensen

 

P18 Ensuring faster patient treatment by reducing turn-around-time for laboratory results

Carsten Thomsen, Claus Brasen, Christian U. Maegaard, Nina Mogensen, Ivan Brandslund

 

P19 Vitamin D in patients with pancreatic diseases

Gianvico Melzi D´eril, Alessandra Barassi, Raffaele Pezzilli

 

P20 Vitamin D and Erectile Dysfunction

Alessandra Barassi, Raffaele Pezzilli, Clara A. L. Damele, Rossana Stefanelli, Giovanni M. Colpi, Massimiliano M. Corsi Romanelli, GianVico Melzi d´Eril

 

P21 ASSESSING THE MITOCHONDRIAL IRON METABOLISM IN HEREDITARY HEMOCHROMATOSIS

Sonia Distante, Ragnhild Skinnes, Kari  Høie, Lars Mørkrid, Lars Eide

P22 The Role Of Early Evaluation Of Porphyrins In Diagnosis Of Acute Porphyria

Galina Zemtsovskaja, Agnes Ivanov, Marika Pikta

 

P23 Can Morning Serum Cortisol Ranges and Action Limits be Harmonised?

Robert Wardrop, Narelle Hadlow

 

P24 An Alpha-Thalassemia Case in Estonia

Marika Pikta, Galina Zemtsovskaja, Iige Viigimaa, Jelena Jerjomina

 

P25 Use of Pyrosequencing for the Detection of Several Polymorphisms Associated with Lactase Persistence

Catherine Herrera, Gunnhild Kravdahl, Malene Nilsen

 

Biomarker development

P26 Effect of fasting on plasma levels of 7-alpha-hydroxy-4-cholesten-3-one – a marker for bile acid synthesis in humans

Magnus Axelson, Kerstin Brismar

 

P27 Detection of antinuclear antibodies – a comparison of indirect immunefluorescence on HEp-2 cells and fluoroenzymeimmunoassay (EliA CTD screen, Thermo Fisher)

Lone Nørgård Troelsen, Søren Jacobsen, Lina Pedersen

 

P28 Measuring gamma-H2AX as a biomarker for DNA damage after ionizing radiation treatment in cancer patients

Pegah Johansson, Aida  Muslimovic, Ragnar Hultborn, Erik Fernström, Ola Hammarsten

 

 

P29 Novel Circulating isoforms of hepcidin

Morten Moe, Tor-Arne Hagve, Ingrid M. Hardang

 

P30 Early diagnosis and calculating the risk of ovarian cancer in women by combining the results of two biomarkers HE4 & CA125

Aaso Raoofi, Adam Molner, Fereshteh Pourlotfi, Tatyana Danylchenko

 

Hematology

P31 Assessment of a diagnostic algorithm to classify von Willebrand disease

Karin Littmann, Maria Berndtsson, Eva-Marie Norberg, Jovan Antovic

 

P32 Trypan Blue accurately defines the viability of CFU-GM cells in Cord Blood Units

Sofia U. Frändberg, Eva Anghem, Inger Ögärd, Lars Palmqvist

 

P33 Exploring the heterogeneity of the hematopoietic stem cell pool: A simultaneous staining protocol for the Side population, Aldehyde dehydrogenase and CD34 in Cord Blood

Sofia U. Frändberg, Susann Li, Cecilia Boreström, Lars Palmqvist

 

P34 Are hemoglobin variants eluting in “variant window” on Bio-Rad Variant Turbo 2.0 affecting the HbA1c results?

Britta Landin, Lena Fredriksson

 

P35 The usefulness of the “Imm Gran?” flag reported on by the Sysmex XE-5000.

Heidi Eilertsen, Tor-Arne Hagve

 

P36 Hypersegmentation in a routin laboratory– a common finding or not?

Anna Maj Ericsson, Helena Orre-Ekdahl, Stefan Jacobsson

 

P37 Evaluation of ‘CellaVision Advanced RBC application’; new software for reporting erythrocyte morphology.

Eva Grönlund, Margit Döry, Agnetha Evers, Soheir Beshara

 

P38 Interference of Monoclonal Antibody Therapies with Serum Protein Electrophoresis Analysis

Claus Brasen, Jakub Krejcik, Torben Plesner

 

P39 Whole exome sequencing of sorted leukemic cells as a complementing method in genetic characterization of acute myeloid leukemia

Erik  Malmberg, Sara Ståhlman, Sofie J. Alm, Tore Samuelsson, Lars Palmqvist, Linda Fogelstrand

 

Point of care testing

P40 Evaluation of HemoCue WBC DIFF system versus Sysmex XE in blood samples from pediatric patients

Anette Friis Larsen, Ole Halfdan Larsen, Anne Dorthe Møller, Søren Ladefoged, Tore Hardlei

 

P41 Harmonizing POCT and Central Core Laboratory analyzers

Anne-Charlotte Wicktorsson, Maria Thornemo

 

P41:2 Assuring quality in point-of-care testing at the Sahlgrenska University Hospital

Anne-Marie Johannesson, Ingrid Uttberg, Maria Thornemo

 

P42 Centralized vs. decentralized blood collection: A comparison of quality indicators for the preanalytical phase.

Erik K. Amundsen, Solrun Fransen, Gro Siri B. Lillesund, Tonje V. Larsen, Karin Toska

 

P43 Like Herding Cats – Information Technology Facilitates Management of Point of Care Testing Systems

Nicole Carney, Robert Dodds, Katrina Moreau, Gregory Sharp

 

P44 Evaluation of three different CRP Point of Care Testing instruments

Slavena Mandic, Marie Palmblad, Laura Goobar Larsson

 

Laboratory education

P45 CLINICAL CHEMISTRY PRACTICE IN REPUBLIC OF MACEDONIA

Jasna Bogdanska, Danica Labudovic

 

Novel company technology

P46 Keeping Bacteria Under Control to Minimize Impact on Assays and Maximize Analyzer Uptime

Stephane Mabic, Maryse Gauthey Baraou, Johan Thorell

 

Other

P47 Integrated EQA

Jonna Pelanti, Samuli Niiranen

 

P48 Method comparison of three automated 25-hydroxy vitamin D enzyme immunoassays to liquid chromatography tandem mass spectroscopy (LCMS/MS) and against each other.

Nada Rakovan, Trine Lauritzen, Per O. Nordstrøm, Øyvind Skadberg

 

P49 Automated alarm to detect antigen excess in serum free immunoglobulin light chain kappa and lambda assays - Experience from routine application.

Karin Toska, Erik K. Amundsen, Petter Urdal, Olav Klingenberg

 

P50 Haemolysis in underfilled venipuncture testtubes

Birgitta Gren

 

P51 Reproducibility problem in an ELISA assay method - fibroblast growth factor 23 (FGF-23) as an example

Henrik Alfthan, Helene Markkanen, Esa Hämäläinen

 

P52 Efficient extraction of human DNA from stool samples and detection of genetic and epigenetic alterations specific for colorectal neoplasia

Aleksandra Mandic Havelka, Annelie Strålfors, Lars-Olof Hansson, Ulrik Lindfors, Gösta Eggertsen

 

P53 PAPP-A2. Median values in normal pregnancy in first trimester and association to Small-For-Gestational-Age infants.

Young Bae Hansen, Vibeke Myrhøj, Finn S. Jørgensen, Claus Oxvig, Steen Sørensen

 

P54 Comparison of two methods for determination of coagulation factor VIII activity

Susanne Samuelsson

 

P55 Evaluation of Technopath Controls on the ARCHITECT Family of Instruments

Jessie Shih, Didier Brault, Antonio Croce, Lieselotte Lennartz, Matthias Orth

 

P56 Comparison of the results of immunoglobulin (IgA,IgG,IgM), IgG subclasses and specific antibodies of patients with frequent sinopulmonary problems.

Elo Saue

 

P57 Clinical chemical monitoring of PFIC-patients treated with a new surgical method

Karin Littmann, Cecilia Gälman, Paolo Parini, Björn Fishler, Antal  Nemeth, Eva Beijer, Maria Magnusson, Ronald Oude-Elferink, Gösta Eggertsen

 

P58 Hidden asymptomatic CDG cases may be mistaken for excessive alcohol consumption

Anders Helander, Jaak Jaeken, Gert Matthijs, Gösta Eggertsen

 

P59 Up-regulation of Liver Enriched Transcription Factors (HNF4a and HNF6) and Liver Specific MicroRNA (MiR-122) by Inhibition of Let-7b in Mesenchymal Stem Cells

Nosratollah Zarghami, Effat Alizadeh, Abolfazl Akbarzadeh, Mohamadreza Baghaban Eslaminejad, Kazem Nejati-Koshki

 

P60 Kidney stone analysis by FTIR

Morten Moe, Marianne Moe, Gunnhild Kravdal

 

P61 Sigma metrics used to assess analytical quality of clinical chemistry assays: Importance of the allowable total error (TEa) target.

Dave Armbruster, Sten A. Westgard

 

P62 Inhibitory Effects of β-Cyclodextrin-Helenalin Complexes on H-TERT Gene Expression in the T47D Breast Cancer Cell Line - Results of Real Time Quantitative PCR

Faraz Zarghami, Abolfazl Akbarzadeh

 

P63 Effect of rest time prior to blood sampling on common biochemical parameter - results from thyreotropin

Ida B. Andersen, Claus L. Brasen, Lene  Nohr-Jensen, Dorthe E. Nielsen, Jonna  S. Madsen

 

P64 SERUM 25HYDROXYVITAMIN D BELOW 75 NMOL/L OBSERVED IN 75% OF HEALTHY SWEDISH ADULTS DURING 75% OF THE YEAR

Göran Oleröd, Eva  Klingberg, Jan Konar, Max Petzold , Ola Hammarsten

 

P65 Effect of apixaban on common coagulation analyses

Inger Fagerberg Blixter and Equalis

Kongress.se